Saxena U - Search Results

1

New approaches for treatment of diabetic nephropathy: the endothelium as a target for drug discovery.

Saxena U, Timmer RT, Pillarisetti S. Saxena U, et al. Expert Opin Ther Targets. 2001 Oct;5(5):539-545. doi: 10.1517/14728222.5.5.539. Expert Opin Ther Targets. 2001. PMID: 12540281

2

Role of oxidative stress and inflammation in the origin of Type 2 diabetes--a paradigm shift.

Pillarisetti S, Saxena U. Pillarisetti S, et al. Among authors: saxena u. Expert Opin Ther Targets. 2004 Oct;8(5):401-8. doi: 10.1517/14728222.8.5.401. Expert Opin Ther Targets. 2004. PMID: 15469391 Review.

3

Lipoprotein lipase as a therapeutic target for dyslipidemia.

Pillarisetti S, Saxena U. Pillarisetti S, et al. Among authors: saxena u. Front Biosci. 2003 Jan 1;8:d238-41. doi: 10.2741/958. Front Biosci. 2003. PMID: 12456348 Review.

4

Atherosclerosis -- new targets and therapeutics.

Pillarisetti S, Alexander CW, Saxena U. Pillarisetti S, et al. Among authors: saxena u. Curr Med Chem Cardiovasc Hematol Agents. 2004 Oct;2(4):327-34. doi: 10.2174/1568016043356246. Curr Med Chem Cardiovasc Hematol Agents. 2004. PMID: 15320783 Review.

5

Lipoic acid synthase (LASY): a novel role in inflammation, mitochondrial function, and insulin resistance.

Padmalayam I, Hasham S, Saxena U, Pillarisetti S. Padmalayam I, et al. Among authors: saxena u. Diabetes. 2009 Mar;58(3):600-8. doi: 10.2337/db08-0473. Epub 2008 Dec 15. Diabetes. 2009. PMID: 19074983 Free PMC article.

6

Novel anti-inflammatory role for glycogen synthase kinase-3beta in the inhibition of tumor necrosis factor-alpha- and interleukin-1beta-induced inflammatory gene expression.

Vines A, Cahoon S, Goldberg I, Saxena U, Pillarisetti S. Vines A, et al. Among authors: saxena u. J Biol Chem. 2006 Jun 23;281(25):16985-16990. doi: 10.1074/jbc.M602446200. Epub 2006 Apr 6. J Biol Chem. 2006. PMID: 16601113 Free article.

7

Inflammatory cytokines and fatty acids regulate endothelial cell heparanase expression.

Chen G, Wang D, Vikramadithyan R, Yagyu H, Saxena U, Pillarisetti S, Goldberg IJ. Chen G, et al. Among authors: saxena u. Biochemistry. 2004 May 4;43(17):4971-7. doi: 10.1021/bi0356552. Biochemistry. 2004. PMID: 15109255

8

Perlecan mediates the antiproliferative effect of apolipoprotein E on smooth muscle cells. An underlying mechanism for the modulation of smooth muscle cell growth?

Paka L, Goldberg IJ, Obunike JC, Choi SY, Saxena U, Goldberg ID, Pillarisetti S. Paka L, et al. Among authors: saxena u. J Biol Chem. 1999 Dec 17;274(51):36403-8. doi: 10.1074/jbc.274.51.36403. J Biol Chem. 1999. PMID: 10593935 Free article.

9

Identification and characterization of the endothelial cell surface lipoprotein lipase receptor.

Saxena U, Klein MG, Goldberg IJ. Saxena U, et al. J Biol Chem. 1991 Sep 15;266(26):17516-21. J Biol Chem. 1991. PMID: 1654330 Free article.

10

Release of endothelial cell lipoprotein lipase by plasma lipoproteins and free fatty acids.

Saxena U, Witte LD, Goldberg IJ. Saxena U, et al. J Biol Chem. 1989 Mar 15;264(8):4349-55. J Biol Chem. 1989. PMID: 2925647 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

166 results

Search Page

Filters